The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 23000 people worldwide and is driven by its mission to unlock new possibilities in life- sciences through quality healthcare solutions that impact lives.
We wish to inform that the company has received the Establishment Inspection Report (EIR) from the USFDA for the inspection conducted at the manufacturing facility of Zydus Lifesciences Limited located at Moraiya, Ahmedabad from 23rd to 27th January, 2023. The inspection was a PAI for Transdermal Patch products. The Audit had ended with NIL observations.
This may kindly be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Please bring the aforesaid news to the notice of the members of the exchange and the investors at large
